Contingent valuation (CV) has been argued to have theoretical advantages over other approaches for benefit valuation used by health economists. Yet, in reality, the technique appears not to have realised these advantages when applied to health-care issues, such that its... View more
Acton, J. P. (1973), Evaluating Public Programs to Save Lives: The Case of Heart Attacks, Santa Monica: R-950-RC, RAND.
Acton, J. P. (1976), 'Measuring the monetary value of lifesaving programs', Law and Contemporary Problems, 40: 46-72.
Adler, M. D. (2006), 'QALYs and policy evaluation: a new perspective', Yale Journal of Health Policy, Law and Ethics, VI: 1-92.
Arrow, K., R. Solow, P. R. Portney, E. E. Leamer, R. Radner and H. Schuman (1993), 'Report of the NOAA panel of contingent valuation', Federal Register, 58: 4601-4614.
Bateman, I., R. T. Carson, B. Day, W. M. Hanemann, N. Hanley, T. Hett, A. Jones, G. Loomes, S. Mourato, E. Ozdemiroglu, D. W. Pearce, R. Sugden and J. Swanson (2002), Economic Valuation with Stated Preferences Techniques. A Manual, Cheltenham: Edward Elgar.
Bleichrodt, H. and J. Quiggin (1999), 'Life-cycle preferences over consumption and health: when is cost-effectiveness analysis equivalent to cost-benefit analysis?', Journal of Health Economics, 18(6): 681-708.
Buxton, M. J. (2005), 'How much are health-care systems prepared to pay to produce a QALY?', European Journal of Health Economics, 6: 285-287.
Byrne, M. M., K. O'malley and M. E. Suarez-Almazor (2005), 'Willingness to pay per quality-adjusted life year in a study of knee osteoarthritis', Medical Decision Making, 25: 655-666.
Cookson, R. (2003), 'Willingness to pay methods in health care: a sceptical view', Health Economics, 12: 891-894.
Covey, J. and R. D. Smith (2006), 'How common is the ''prominence effect''? Additional evidence to Whynes et al.', Health Economics, 15: 205-210.